Institut Straumann AG Company Profile

10:19 EDT 19th March 2018 | BioPortfolio

Straumann is a global leader in implant dentistry and oral tissue regeneration. For more than half a century, our company has been driven by passion for scientific discovery and belongs to the pioneers of modern dental implantology.
Straumann researches, develops, produces and distributes dental implants, instruments and tissue regeneration products. We work closely with the International Team for Implantology (ITI), an independent international network of eminent clinicians and researchers, as well as leading clinics, research institutes and universities.


Peter Merian-Weg 12
CH 4052


Phone: 41 61 965 11 11
Fax: 41 61 965 11 01

News Articles [99 Associated News Articles listed on BioPortfolio]

Book release: 'Institut Pasteur: Today's Research, Tomorrow's Medicine'

(Institut Pasteur) As the Institut Pasteur enters the 130th year of its existence (the anniversary will be celebrated on Nov. 14, 2018), the book Institut Pasteur: Today's Research, Tomorrow's Medicin...

Institut Curie, Pierre Fabre Partner on immuno-oncology

Institut Curie and the IRPF (Institut de Recherche Pierre Fabre) will collaborate on new therapeutic strategies to advance cancer treatment for patients. The objective of this novel partnership is to ...

High incidence of neonatal infections in Madagascar

(Institut Pasteur) Every year in the world, 4 million children die before the age of one, mainly in resource-limited countries, one-third of them due to a severe infection. In 2012, the Institut Paste...

Sanofi and the Institut Pasteur reward five researchers in the service of human health

(Institut Pasteur) Paris, France - December 13th 2017 - Sanofi and the Institut Pasteur presented the Sanofi - Institut Pasteur Awards for the sixth year in a row. Five internationally recognized rese...

Five Institut Pasteur scientists receive 2017 L'Oréal-UNESCO Fellowships

(Institut Pasteur) On October 11, five young scientists at the Institut Pasteur received 2017 L'Oréal-UNESCO "For Women in Science" Fellowships. Through their research, they are helping to advance sc...

Quiescent cells also mutate

(Institut Pasteur) For almost a hundred years, geneticists have believed that the more a cell divides the more mutations it acquires. However, research by scientists at the Institut Pasteur shows that...

Genes play a role in empathy

(Institut Pasteur) A new study led by scientists from the University of Cambridge, the Institut Pasteur, Paris Diderot University, the CNRS and the genetics company 23andMe suggests that our empathy i...

Straumann Holding AG ADR 2017 Q4 - Results - Earnings Call Slides

Drugs and Medications [0 Results]


PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

A Prospective Case-Control Clinical Study of Titanium-Zirconium Alloy Implants with a Hydrophilic Surface in Patients with Type 2 Diabetes Mellitus.

To evaluate prospectively the behavior of narrow-diameter (3.3-mm) titanium-zirconium alloy implants with a hydrophilic surface (Straumann Roxolid SLActive) in patients with type 2 diabetes mellitus i...

Enrollment in early-phase clinical trials in pediatric oncology: The experience at Institut Curie.

The European Paediatric Regulation was introduced in 2007 to facilitate access to new medicines for children. Our study explored accessibility of early-phase trials in pediatric oncology, in line with...

Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave Roussy.

Everolimus (E) and axitinib (A) have been standard treatments for patients with metastatic renal cell carcinoma after failure of first-line therapy (1L) with vascular endothelial growth factor-targete...

2017 international meeting of the Global Virus Network.

The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 40 GVN C...

Evaluation of Bone Stability and Esthetic Results After Immediate Implant Placement Using a Novel Synthetic Bone Substitute in the Anterior Zone: Results After 12 Months.

The aim of this study was to assess bone and soft tissue changes after tooth extraction and immediate implant insertion in the anterior maxilla. A novel synthetic bone graft (VivOss, Straumann) was us...

Clinical Trials [44 Associated Clinical Trials listed on BioPortfolio]

Maxillary Sinus Elevation With Bio-Oss or Straumann BoneCeramic

The purpose of the study was to test a clinically relevant non-inferiority of Straumann BoneCeramic treatment compared to Bio-Oss treatment 180 to 240 days after sinus grafting procedure...

Straumann Bone Ceramic Versus BioOss in Sinus Elevation

Straumann Bone Ceramic (SBC) and BioOss will be used as bone grafting materials when there is a need for bone augmentation in the posterior upper jaw. 9 months later the bone formation is ...

Single Tooth Restoration in the Maxilla Using the Straumann® PURE® Ceramic Implant Monotype: One Year Follow up

The main objective is to evaluate peri-implant hard and soft tissues's stability with the use of a ceramic implant (Implant Straumann®Pure Ceramic) during one year follow up.

Comparison of Early and Late Loading in the Edentulous Upper Jaw Using Cresco Prosthetic System on Straumann Implants

Comparison of early and late loading of implants supporting full each prosthesis in upper jaw, using the Cresco prosthetic system on Straumann implants. The study hypothesis is that there ...

Comparison of Synthetic Bone Substitute and a Bovine-Derived Xenograft in Horizontal Bone Augmentation

The objective of the study is to test the efficacy on bone formation of Straumann Bone Ceramic as a grafting material applied in buccal bone dehiscences on simultaneously placed oral impla...

Companies [42 Associated Companies listed on BioPortfolio]

Institut Straumann AG

Straumann is a global leader in implant dentistry and oral tissue regeneration. For more than half a century, our company has been driven by passion for scientific discovery and belongs to the pioneer...

Statens Serum Institut

Statens Serum Institut is a public enterprise operating as a market-oriented production and service enterprise.Statens Serum Institut is an enterprise under the Danish Ministry of the Interior and Hea...

Institut Pasteur

The Institut Pasteur is a non-profit foundation dedicated to the prevation and treatment of diseases through biological research,education and public health activites

institut merieux

With extensive experience in industrial microbiology, Institut Merieux contributes to serving medicine and public health across the globe. For the fight against infectious diseases and cancer, it ...


Straumann is a global leader in implant dentistry and oral tissue regeneration. For more than half a century, our company has been driven by passion for scientific discovery and belongs to the pioneer...

More Information about "Institut Straumann AG" on BioPortfolio

We have published hundreds of Institut Straumann AG news stories on BioPortfolio along with dozens of Institut Straumann AG Clinical Trials and PubMed Articles about Institut Straumann AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Institut Straumann AG Companies in our database. You can also find out about relevant Institut Straumann AG Drugs and Medications on this site too.

Quick Search


Relevant Topics

Dentistry is the study, management and treatment of diseases and conditions affecting the mouth, jaw, teeth and their supporting tissues (Oxford Medical Dictionary) The work of a dentist ranges from regular patient check-up to orthodontics and surgery....

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record